CAS: 217466-37-0

1β-Hydroxy-2-oxopomolic acid inhibits adipocyte differentiation through downregulation of various adipocytokines by blocking PPARγ and C/EBPα expression.

1-Hydroxy-2-oxopomolic acid is a pentacyclic triterpenoid compound, which is derived from the natural triterpenoid pomolic acid. This molecule is typically sourced from various plant species known for their therapeutic properties, particularly within traditional medicine systems. The mode of action of 1-Hydroxy-2-oxopomolic acid involves its interaction with cellular pathways related to anti-inflammatory and anti-cancer processes. The compound exhibits the ability to modulate signaling pathways, thereby affecting gene expression and cellular apoptosis in target cells. This mode of action makes it a subject of interest in pharmacological research. In terms of applications, 1-Hydroxy-2-oxopomolic acid is primarily researched for its potential in developing new therapeutic agents. Its anti-inflammatory and cytotoxic properties make it a candidate for studies in oncology and immunology. Ongoing research is exploring its efficacy in various models of disease to better understand its potential clinical uses. The compound is an exciting area of study for scientists investigating alternative and complementary therapeutics.